Novelty Nobility Inc. Alternatives & Competitors

12 companies similar to Novelty Nobility Inc. — Novel Science, Noble Management

Fortis Therapeutics

Pioneering antibody-drug conjugate therapies to combat late-stage multiple myeloma and pro...

Series A $58.00M

Biotechnology Health and Wellness

ProfoundBio

An oncology biotherapeutics company

8 Series B $247.00M

Woodinville, United State...

Biotechnology Health and Wellness

Immunitas Therapeutics

The Human Approach to Oncology

33 Series B $97.00M

Waltham, United States

Biotechnology Health Care +2

BioDlink(TOT BIOPHARM)

Empowering Pharmaceutical Innovation, Improving Quality of Life, Safeguarding Human Health

80 Series B $108.00M

China

Biopharma Biotechnology +2

Rival Readout

Competing with Novelty Nobility Inc.? We do this properly.

10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.

Book a 7-day Readout

Henlius

Reliable Quality · Affordable Innovation

492 Venture round $346.00M

Shanghai, China

Biotechnology Health Care +1

ABL Bio Inc.

A global leader in bispecific antibody therapeutics for immuno-oncology and neurodegenerat...

64 IPO $49.12B

Seoul, Korea South

Biotechnology Health Care

Compare

Mythic Therapeutics, Inc.

Charting a new dimension in ADC technology

53 Series B $126.60M

Waltham, United States

Biotechnology Health Care +3

AsclepiX Therapeutics

Fraud Alert Regarding Third Party Employment Agencies

8 Series A $50.00M

Baltimore, United States

Biotechnology Health Care +1

Arcus Biosciences

Biopharmaceutical company developing differentiated molecules and combination therapies fo...

633 IPO $1.86B

Hayward, United States

Biopharma Biotechnology +3

Pheon Therapeutics

Pheon is an Antibody-Drug Conjugate specialist developing next generation ADCs for a range...

26 Series B $188.00M

London, United Kingdom

Biotechnology Health and Wellness +1

ADC Biotechnology

Accelerating solutions for developers to overcome conjugation challenges, making new ADC-b...

Venture round $16.33M

Biopharma Biotechnology +1

VBL Therapeutics (Nasdaq:VBLT)

Engineering the future of targeted medicines, breaking barriers to develop the next genera...

15 Post-IPO Equity $62.76M

Israel

Biotechnology Health Care +1

About Novelty Nobility Inc.

Novelty Nobility Inc. is a private clinical stage biotech company located in Pangyo, South Korea, and Boston, Massachusetts. Founded in 2017, the company is focused on the research of novel angiogenesis targets and developing antibody-based therapeutics in ophthalmology and oncology.

Business keywords

Biotech, Clinical Stage, Angiogenesis Research, Antibody-Based Therapeutics, Ophthalmology, Oncology, Drug Development, Stem Cell Factor, C-KIT, Monoclonal Antibody, ADC (Antibody-Drug Conjugate)

Frequently Asked Questions

Companies similar to Novelty Nobility Inc. include Fortis Therapeutics, ProfoundBio, Immunitas Therapeutics, BioDlink(TOT BIOPHARM), Henlius. They work in Biotechnology and Health Care and share Novelty Nobility Inc.'s focus on oncology, drug development and biotech.

Bounce Watch lists 12 companies that share Novelty Nobility Inc.'s industries and are closest to it in business tags, services, target customers, business model and size.

From the desk

Mapping a market? Start with a Rival Readout.

In 7 business days we read 10 rivals around Novelty Nobility Inc.: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.

Book a 7-day Readout Get a free snapshot

Explore Related

Novelty Nobility Inc. Profile Fortis Therapeutics Alternatives ProfoundBio Alternatives Immunitas Therapeutics Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Novelty Nobility Inc. on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.